HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Posa Selected Research

1- (4- (benzothiazol- 2- yloxy)benzyl)piperidine- 4- carboxylic acid

3/2008Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Posa Research Topics

Disease

2Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2016
1Lung Neoplasms (Lung Cancer)
08/2019
1Neoplasms (Cancer)
08/2019
1Osteoporosis
01/2014
1Glycogen Storage Disease Type II (Pompe's Disease)
01/2014
1Muscular Diseases (Myopathy)
01/2014
1Inclusion Body Myositis
01/2014
1Dry Eye Syndromes (Dry Eye Syndrome)
11/2010
1Cardiovascular Diseases (Cardiovascular Disease)
05/2009
1Inflammation (Inflammations)
03/2008
1Colitis
03/2008
1Necrosis
03/2008
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2008

Drug/Important Bio-Agent (IBA)

1degradable starch microspheresIBA
01/2016
1Sorafenib (BAY 43-9006)FDA Link
01/2016
1SteroidsIBA
01/2014
1Surface-Active Agents (Surfactants)IBA
11/2010
11- (4- (benzothiazol- 2- yloxy)benzyl)piperidine- 4- carboxylic acidIBA
03/2008
1AcidsIBA
03/2008
1Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
03/2008
1HydrolasesIBA
03/2008
1leukotriene A4 hydrolaseIBA
03/2008
1Leukotriene B4IBA
03/2008
1Peroxidase (Myeloperoxidase)IBA
03/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2008
1Interleukin-6 (Interleukin 6)IBA
03/2008
1CytokinesIBA
03/2008
1Leukotriene A4IBA
03/2008

Therapy/Procedure

1Radiofrequency Therapy
01/2022
1Electrodes (Electrode)
08/2019
1Radiofrequency Ablation
08/2019
1Drug Therapy (Chemotherapy)
01/2016
1Contraindications
01/2016
1Therapeutics
05/2009
1Oral Administration
03/2008